Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazanin Sareban

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Clinical Laboratory Analysis|May 7, 2014
Platelet antibody analysis by three different testsNazanin Sareban, Susanne Macher, Camilla Drexler, et al.
Trials|October 30, 2016
High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trialSusanne Macher, Camilla Drexler, Ines Lindenau, et al.
Cancer Medicine|June 28, 2022
Impact of allogeneic red blood cell transfusion on prognosis in soft tissue sarcoma patients. A single-centre studyMaria Anna Smolle, Wolfgang Helmberg, Eva Maria Matzhold, et al.
The Journal of Infection|August 25, 2021
Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort studySabrina Kral, Chiara Banfi, Tobias Niedrist, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2023
Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stageChristoph Buchta, David Springer, Jovana Jovanovic, et al.
The Journal of Infection|October 30, 2020
SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemiaKatharina Guetl, Florentine Moazedi-Fuerst, Konrad Rosskopf, et al.
Frontiers in Immunology|December 24, 2021
CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised PatientsEduard Schulz, Isabel Hodl, Patrick Forstner, et al.
Annals of Intensive Care|May 12, 2021
Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational studyStefan Hatzl, Florian Posch, Nazanin Sareban, et al.
Diabetes, Obesity & Metabolism|September 4, 2022
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort studyCaren Sourij, Faisal Aziz, Harald Kojzar, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Laboratory Analysis|May 7, 2014
Platelet antibody analysis by three different testsNazanin Sareban, Susanne Macher, Camilla Drexler, et al.
Trials|October 30, 2016
High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trialSusanne Macher, Camilla Drexler, Ines Lindenau, et al.
Cancer Medicine|June 28, 2022
Impact of allogeneic red blood cell transfusion on prognosis in soft tissue sarcoma patients. A single-centre studyMaria Anna Smolle, Wolfgang Helmberg, Eva Maria Matzhold, et al.
The Journal of Infection|August 25, 2021
Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort studySabrina Kral, Chiara Banfi, Tobias Niedrist, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2023
Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stageChristoph Buchta, David Springer, Jovana Jovanovic, et al.
The Journal of Infection|October 30, 2020
SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemiaKatharina Guetl, Florentine Moazedi-Fuerst, Konrad Rosskopf, et al.
Frontiers in Immunology|December 24, 2021
CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised PatientsEduard Schulz, Isabel Hodl, Patrick Forstner, et al.
Annals of Intensive Care|May 12, 2021
Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational studyStefan Hatzl, Florian Posch, Nazanin Sareban, et al.
Diabetes, Obesity & Metabolism|September 4, 2022
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort studyCaren Sourij, Faisal Aziz, Harald Kojzar, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Pageof 2